These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17646609

  • 1. Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes.
    LaPointe NM, Chen AY, Alexander KP, Roe MT, Pollack CV, Lytle BL, Ohman ME, Gibler BW, Peterson ED.
    Arch Intern Med; 2007 Jul 23; 167(14):1539-44. PubMed ID: 17646609
    [Abstract] [Full Text] [Related]

  • 2. Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.
    Spinler SA, Ou FS, Roe MT, Gibler WB, Ohman EM, Pollack CV, Alexander KP, Peterson ED.
    Pharmacotherapy; 2009 Jun 23; 29(6):631-8. PubMed ID: 19476416
    [Abstract] [Full Text] [Related]

  • 3. Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction.
    Wang TY, Chen AY, Alexander KP, Ohman EM, Gibler WB, Peterson ED, Roe MT.
    Am J Med; 2008 Sep 23; 121(9):805-10. PubMed ID: 18724971
    [Abstract] [Full Text] [Related]

  • 4. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW.
    Circulation; 2007 Dec 04; 116(23):2669-77. PubMed ID: 18025532
    [Abstract] [Full Text] [Related]

  • 5. Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes.
    Melloni C, Alexander KP, Chen AY, Newby LK, Roe MT, Allen LaPointe NM, Pollack CV, Gibler WB, Ohman EM, Peterson ED, CRUSADE Investigators.
    Am Heart J; 2008 Aug 04; 156(2):209-15. PubMed ID: 18657648
    [Abstract] [Full Text] [Related]

  • 6. A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study.
    Simoons ML, Bobbink IW, Boland J, Gardien M, Klootwijk P, Lensing AW, Ruzyllo W, Umans VA, Vahanian A, Van De Werf F, Zeymer U, PENTUA Investigators.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2183-90. PubMed ID: 15193678
    [Abstract] [Full Text] [Related]

  • 7. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
    Lopes RD, Alexander KP, Marcucci G, White HD, Spinler S, Col J, Aylward PE, Califf RM, Mahaffey KW.
    Eur Heart J; 2008 Aug 16; 29(15):1827-33. PubMed ID: 18519426
    [Abstract] [Full Text] [Related]

  • 8. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.
    Melloni C, Peterson ED, Chen AY, Szczech LA, Newby LK, Harrington RA, Gibler WB, Ohman EM, Spinler SA, Roe MT, Alexander KP.
    J Am Coll Cardiol; 2008 Mar 11; 51(10):991-6. PubMed ID: 18325437
    [Abstract] [Full Text] [Related]

  • 9. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW, Tonev ST, Spinler SA, Levine GN, Gallo R, Ducas J, Goodman SG, Antman EM, Becker RC, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM, SYNERGY Trial Investigators.
    Int J Cardiol; 2010 Mar 04; 139(2):123-33. PubMed ID: 19012977
    [Abstract] [Full Text] [Related]

  • 10. Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice.
    Zeymer U, Gitt A, Jünger C, Koeth O, Zahn R, Wienbergen H, Gottwik M, Senges J, ACOS-Registry Participants.
    Am J Cardiol; 2006 Jul 01; 98(1):19-22. PubMed ID: 16784913
    [Abstract] [Full Text] [Related]

  • 11. Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes.
    Roe MT, Chen AY, Mehta RH, Li Y, Brindis RG, Smith SC, Rumsfeld JS, Gibler WB, Ohman EM, Peterson ED.
    Circulation; 2007 Sep 04; 116(10):1153-61. PubMed ID: 17709638
    [Abstract] [Full Text] [Related]

  • 12. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry.
    Ryan JW, Peterson ED, Chen AY, Roe MT, Ohman EM, Cannon CP, Berger PB, Saucedo JF, DeLong ER, Normand SL, Pollack CV, Cohen DJ, CRUSADE Investigators.
    Circulation; 2005 Nov 15; 112(20):3049-57. PubMed ID: 16275863
    [Abstract] [Full Text] [Related]

  • 13. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE).
    Alexander D, Ou FS, Roe MT, Pollack CV, Ohman EM, Cannon CP, Gibler WB, Fintel DJ, Peterson ED, Brown DL, American College of Cardiology/American Heart Association.
    Am Heart J; 2008 Sep 15; 156(3):606-12. PubMed ID: 18760147
    [Abstract] [Full Text] [Related]

  • 14. Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events.
    Diercks DB, Roe MT, Chen AY, Peacock WF, Kirk JD, Pollack CV, Gibler WB, Smith SC, Ohman M, Peterson ED.
    Ann Emerg Med; 2007 Nov 15; 50(5):489-96. PubMed ID: 17583379
    [Abstract] [Full Text] [Related]

  • 15. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
    Morrow DA, Antman EM, Murphy SA, Qin J, Ruda M, Guneri S, Jacob AJ, Budaj A, Braunwald E, TIMI Study Group.
    Am Heart J; 2007 Dec 15; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
    [Abstract] [Full Text] [Related]

  • 16. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative.
    Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV, Brindis RG, Gibson CM, Kleiman NS, Saucedo JF, Bhatt DL, Gibler WB, Ohman EM, Harrington RA, Roe MT.
    Am Heart J; 2006 Oct 15; 152(4):641-7. PubMed ID: 16996828
    [Abstract] [Full Text] [Related]

  • 17. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
    Leung S, Gallup D, Mahaffey KW, Cohen M, Antman EM, Goodman SG, Harrington RA, Langer A, Aylward P, Ferguson JJ, Califf RM, SYNERGY Trial Investigators.
    Am Heart J; 2008 Jul 15; 156(1):177-84. PubMed ID: 18585514
    [Abstract] [Full Text] [Related]

  • 18. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S, Morrow DA, Sloan S, Antman EM, Sabatine MS.
    Circulation; 2009 Mar 10; 119(9):1195-202. PubMed ID: 19237657
    [Abstract] [Full Text] [Related]

  • 19. Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative.
    Pollack CV, Hollander JE, Chen AY, Peterson ED, Bangalore S, Peacock FW, Cannon CP, Canto JG, Gibler BW, Ohman ME, Roe MT.
    Crit Pathw Cardiol; 2009 Mar 10; 8(1):29-33. PubMed ID: 19258835
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative.
    Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT, Hong MK, Peterson ED, CRUSADE Investigators.
    Am Heart J; 2009 Mar 10; 157(3):525-31. PubMed ID: 19249424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.